G S Sachin Clinical Guide to Antidepressant Switching This guide provides clinical context for the principles and strategies involved in changing a patient’s antidepressant medication. About Antidepressant Switching Switching antidepressants is a common clinical practice when a patient’s current medication is ineffective or causes intolerable side effects. The Switching Antidepressants Calculator is a clinical support tool designed to … Read more
About the MME Calculator The MME (Morphine Milligram Equivalent) Calculator is a clinical decision support tool designed for healthcare professionals. It standardizes the calculation of a patient’s total daily opioid dosage into a universal value, the morphine milligram equivalent (MME), to help assess the risk of overdose. MME is a critical metric in opioid stewardship, … Read more
About This Calculator This Opioid Conversion Calculator is a clinical support tool designed to help healthcare professionals calculate an equianalgesic dose when switching a patient from one or more opioids to another. It uses standard Morphine Milligram Equivalent (MME) conversion factors to estimate a new total daily dose (TDD), incorporating a crucial safety reduction for … Read more
About This Tool The Methylphenidate Dose Calculator is a clinical support tool designed for healthcare professionals to assist in the dosing of various methylphenidate formulations for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). It helps determine appropriate starting doses, titration schedules, maximum daily limits, and provides estimates for converting between different product formulations. Outputs Explained Based … Read more
About This Calculator The Strattera Dose Calculator provides dosing recommendations for atomoxetine based on current prescribing guidelines for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). It considers critical patient factors including age, weight, hepatic function, and concurrent use of strong CYP2D6 inhibitors to suggest an appropriate dosing schedule. This tool is intended for educational purposes for … Read more
About This Conversion Tool The Vyvanse to Adderall conversion calculator is an educational resource designed to help estimate equivalent dosages between lisdexamfetamine (Vyvanse) and mixed amphetamine salts (Adderall IR/XR). The conversion is based on the molecular weight and pharmacokinetic properties of these medications. This tool provides a clinically relevant starting point for professionals considering a … Read more
About this Calculator The Concerta Dose Calculator provides dosing guidance based on the official FDA-approved prescribing information. It is designed to assist qualified healthcare professionals in determining appropriate starting doses, titration schedules, and conversion strategies from immediate-release (IR) methylphenidate for patients with Attention-Deficit/Hyperactivity Disorder (ADHD). Disclaimer: This information is for educational purposes and is not … Read more
Clinical & Dosing Information This information complements the calculator and is intended for healthcare professionals. It is not a substitute for clinical judgment or professional medical advice. About This Calculator The Adderall to Vyvanse conversion calculator is an educational tool designed to estimate an approximate equivalent starting dose of Vyvanse (lisdexamfetamine) for a patient currently … Read more
About This Calculator This Adderall Dose Calculator provides educational information on standard dosing regimens for mixed amphetamine salts, based on FDA-approved prescribing guidelines. It is designed to assist healthcare professionals in understanding typical starting doses, titration schedules, and maximum recommended dosages for different patient populations and indications. Outputs Explained After inputting patient data, the calculator … Read more
About This information guide provides context for using the Vyvanse® Dose Calculator. The calculator is designed to assist healthcare professionals by providing dosing recommendations based on FDA-approved prescribing information for Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED) in adults. The guidance covers initial dosing, titration schedules, adjustments for renal impairment, and … Read more
